Genesee Capital Advisors’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-36,394
| Closed | -$1.19M | – | 134 |
|
|
2024
Q1 | $1.19M | Sell |
36,394
-1,996
| -5% | -$65.4K | 0.65% | 40 |
|
|
2023
Q4 | $1.27M | Buy |
38,390
+825
| +2% | +$27.3K | 0.78% | 35 |
|
|
2023
Q3 | $1.02M | Sell |
37,565
-3,031
| -7% | -$82.5K | 0.74% | 37 |
|
|
2023
Q2 | $1.23M | Sell |
40,596
-34,280
| -46% | -$1.04M | 0.84% | 33 |
|
|
2023
Q1 | $2.43M | Sell |
74,876
-1,360
| -2% | -$44.1K | 1.73% | 14 |
|
|
2022
Q4 | $2.14M | Sell |
76,236
-5,934
| -7% | -$167K | 1.6% | 14 |
|
|
2022
Q3 | $2.95M | Sell |
82,170
-1,461
| -2% | -$52.5K | 2.25% | 11 |
|
|
2022
Q2 | $2.57M | Sell |
83,631
-13,550
| -14% | -$416K | 1.79% | 13 |
|
|
2022
Q1 | $3.14M | Sell |
97,181
-2,362
| -2% | -$76.3K | 1.64% | 14 |
|
|
2021
Q4 | $2.75M | Sell |
99,543
-5,960
| -6% | -$165K | 1.31% | 20 |
|
|
2021
Q3 | $3.27M | Buy |
+105,503
| New | +$3.27M | 1.61% | 13 |
|